Jin Medical International Ltd. income statement ZJYL
In fiscal 2025, which ended Sep 30, 2025, Jin Medical International Ltd. reported revenue of $20.7 million, down 12.0% from the year before. Net income was $1.2 million, a profit margin of 5.8%. Operating income came to $608,182, an operating margin of 2.9%. Diluted earnings per share were $0.01.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2025
Sep 30, 2025
|
FY 2024
Sep 30, 2024
|
FY 2023
Sep 30, 2023
|
|---|---|---|---|
| Revenue |
21
-12.0%
|
24
+18.6%
|
20
|
| Cost of revenue |
15
+4.6%
|
14
+7.4%
|
13
|
| Gross profit |
6
-36.4%
|
10
+40.1%
|
7
|
| Research and development |
2
+4.0%
|
1
-3.0%
|
2
|
| Selling, general and administrative |
4
-11.2%
|
4
+83.9%
|
2
|
| Operating expenses |
5
-7.3%
|
6
|
4
|
| Operating income |
1
-83.3%
|
4
+26.9%
|
3
|
| Other income (expense) |
1
+81.2%
|
1
|
—
|
| Pretax income |
2
-61.9%
|
4
+29.9%
|
3
|
| Income tax |
0
-71.9%
|
1
+122.2%
|
0
|
| Net income |
1
-67.6%
|
4
+27.7%
|
3
|
| Basic EPS |
0.01
-50.0%
|
0.02
+0.0%
|
0.02
|
| Diluted EPS |
0.01
-50.0%
|
0.02
+0.0%
|
0.02
|
| Weighted average shares, basic |
157
+0.0%
|
156
+7.8%
|
145
|
| Weighted average shares, diluted |
157
+0.0%
|
156
+7.8%
|
145
|
| Other measures | |||
| Depreciation and amortization |
0
+2.3%
|
0
+5.3%
|
0
|
| EBITDA |
1
-78.0%
|
4
+25.3%
|
3
|
| Margins | |||
| Gross margin |
29.22%
|
40.43%
|
34.23%
|
| Operating margin |
2.94%
|
15.48%
|
14.47%
|
| Pretax margin |
7.71%
|
17.80%
|
16.25%
|
| Profit margin |
5.76%
|
15.64%
|
14.52%
|
| EBITDA margin |
4.12%
|
16.49%
|
15.61%
|
| Effective tax rate |
13.45%
|
18.26%
|
10.67%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- ZJYL (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- Cayman Islands
- Headquarters
- Jiangsu Province, China
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1837821
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.